These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16252554)

  • 1. Generic drugs.
    Tuorto S; Hezel M; Marsh L; Eisenberg DP; Adusumilli PS
    Natl Med J India; 2005; 18(4):210-1. PubMed ID: 16252554
    [No Abstract]   [Full Text] [Related]  

  • 2. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 3. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 4. A generic problem.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Free trade agreements make the drugs more expensive].
    Jeppsson A
    Lakartidningen; 2009 Nov 18-24; 106(47):3181. PubMed ID: 20082499
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic drugs. Does inexpensive mean cheap?
    Dinsmoor RS
    Diabetes Self Manag; 2004; 21(1):8-10, 12. PubMed ID: 15025019
    [No Abstract]   [Full Text] [Related]  

  • 7. [Patients, patents and profits].
    Roland PC
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):205. PubMed ID: 18202741
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin utilisation--recognising the role of the invisible hand.
    Minhas R
    Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS drugs. Brazil, Thailand override big pharma patents.
    Cohen J
    Science; 2007 May; 316(5826):816. PubMed ID: 17495145
    [No Abstract]   [Full Text] [Related]  

  • 10. [The patent is "engine" in drug development].
    Bergström R
    Lakartidningen; 2008 Mar 5-11; 105(10):752. PubMed ID: 18422246
    [No Abstract]   [Full Text] [Related]  

  • 11. [Discount for only one drug of the same group leads to impaired health care quality].
    Bergström R
    Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
    [No Abstract]   [Full Text] [Related]  

  • 12. White paper. The five myths of generic competition. A Pharma Matters report. March 2009.
    Drug News Perspect; 2009 Apr; 22(3):171-5. PubMed ID: 19440560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What drug companies actually do].
    Tonby K
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1806. PubMed ID: 17599137
    [No Abstract]   [Full Text] [Related]  

  • 15. Handle with care.
    Macilwain C
    Nature; 2006 Apr; 440(7087):990-1. PubMed ID: 16625170
    [No Abstract]   [Full Text] [Related]  

  • 16. Bills target biosimilar drugs.
    Wadman M
    Nature; 2009 Mar; 458(7237):394-5. PubMed ID: 19325595
    [No Abstract]   [Full Text] [Related]  

  • 17. Market watch: Sales of biologics to show robust growth through to 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035
    [No Abstract]   [Full Text] [Related]  

  • 18. Supreme Court rules against drug patent "evergreening".
    Kondro W
    CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081
    [No Abstract]   [Full Text] [Related]  

  • 19. India's new patent bill threatens generic industry.
    Ahmad K
    Lancet Infect Dis; 2005 May; 5(5):265. PubMed ID: 15889471
    [No Abstract]   [Full Text] [Related]  

  • 20. Are patent expirations the answer to improving patient adherence?
    Klepser DG
    Am J Manag Care; 2008 Dec; 14(12):787-8. PubMed ID: 19067495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.